This inventor holds 1 USPTO granted patent. Top assignees: Snu Rdb Foundation, The Asan Foundation, University of Ulsan Foundation for Industry Cooperation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 549 
1 out of 84 
1 out of 94 
Years Active: 2023
Title: The Innovative Contributions of Eunhee Koh
Introduction
Eunhee Koh, an innovative inventor based in Seoul, South Korea, has made a significant impact in the field of pharmaceutical compositions. With one patent to her name, she has focused her research on addressing non-alcoholic steatohepatitis (NASH), a condition that affects liver health.
Latest Patents
Eunhee Koh's patent, titled "S1PR4-targeting composition for preventing or treating non-alcoholic steatohepatitis," presents a groundbreaking approach to tackling this prevalent liver disease. This invention details a pharmaceutical composition and a health functional food composition that includes a sphingolipid compound acting as a functional inhibitor against S1PR4. The potential applications of this compound lie in its ability to prevent or treat NASH by reducing inflammatory cell infiltration in hepatic tissues, suppressing fibrosis, and decreasing liver injury markers such as ALT. This innovative approach highlights the promising therapeutic effects that Eunhee's invention could have on liver health.
Career Highlights
Throughout her career, Eunhee Koh has collaborated with notable institutions such as the University of Ulsan Foundation for Industry Cooperation and The Asan Foundation. Her work in these organizations has contributed to advancements within the research community, particularly in the realm of liver health and disease prevention.
Collaborations
Eunhee Koh has worked alongside distinguished colleagues such as Kiup Lee and Sanghee Kim. These collaborations have helped to enhance the research output and innovation potential of her projects, leading to significant strides in tackling liver-related diseases.
Conclusion
In conclusion, Eunhee Koh stands out as a prominent inventor in the field of non-alcoholic steatohepatitis treatment. Her innovative patent offers prospective solutions to a critical health issue, reflecting her dedication to improving liver health through research and invention. As her career progresses, it will be exciting to see the further advancements and contributions she will bring to the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile